» Articles » PMID: 32525880

Outcomes of Kidney Transplantation from Elderly Deceased Donors of a Korean Registry

Overview
Journal PLoS One
Date 2020 Jun 12
PMID 32525880
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

To overcome organ shortage, expanded criteria donors, including elderly deceased donors (DDs), should be considered. We analyzed outcomes of kidney transplantation (KT) from elderly DDs in a nationwide study. In total, data of 1049 KTs from DDs using the database of Korean Organ Transplantation Registry (KOTRY) were retrospectively analyzed based on the age of DDs: age ≥60 years vs. <60 years. Clinical information, graft status, and adverse events were reviewed in DDs and recipients. The mean age of the 1006 DDs was 51.04±10.54 years, and 21.5% of donors were aged ≥60 years. Elderly DDs had a significantly higher prevalence of diabetes and hypertension and higher Kidney Donor Risk Index (KDRI) and Kidney Donor Profile Index (KDPI). The mean age of the recipients was 47.45±14.87 years. Patients who received KT from elderly DDs were significantly older (53.12±15.14 vs. 45.88±14.41, P<0.001) and had a higher rate of diabetes (41.9 vs. 24.4%, P<0.001). Graft outcomes were not significantly different. Renal function was similar between the groups at the time of discharge and at 6 months, 1 year, and 2 years after KT. The rate of delayed graft function (DGF) was not significantly different. Risk factors of DGF were significantly different in DDs aged ≥60 years and <60 years. In the multivariable model, male sex (odds ratio: 3.99, 95% confidence interval: 1.42-11.22; P = 0.009) and KDRI (12.17, 2.23-66.34; P = 0.004) were significant risk factors for DGF in DDs aged ≥60 years. In DDs aged <60 years, thymoglobulin induction (2.62, 1.53-4.48; P<0.001) and continuous renal replacement therapy (3.47, 1.52-7.96; P = 0.003) were significant factors. Our data indicated that graft outcomes, including renal function and DGF, were similar for elderly DDs and DDs aged <60 years. Elderly DDs might be considered tolerable donors for KT, with active preoperative surveillance.

Citing Articles

The comparative efficacy and safety of basiliximab and antithymocyte globulin in deceased donor kidney transplantation: a multicenter cohort study.

Hong S, Kim Y, Jin K, Han S, Yang C, Chung B Kidney Res Clin Pract. 2023; 42(1):138-148.

PMID: 36747359 PMC: 9902729. DOI: 10.23876/j.krcp.21.159.


Effect of Long Cold Ischemia Time of Kidneys from Aged Donors on Prognosis of Kidney Transplantation.

Liu L, Cheng K, Huang J Ann Transplant. 2021; 26:e928735.

PMID: 34663778 PMC: 8540027. DOI: 10.12659/AOT.928735.

References
1.
Englum B, Schechter M, Irish W, Ravindra K, Vikraman D, Sanoff S . Outcomes in kidney transplant recipients from older living donors. Transplantation. 2015; 99(2):309-15. DOI: 10.1097/TP.0000000000000607. View

2.
Ruggenenti P, Silvestre C, Boschiero L, Rota G, Furian L, Perna A . Long-term outcome of renal transplantation from octogenarian donors: A multicenter controlled study. Am J Transplant. 2017; 17(12):3159-3171. DOI: 10.1111/ajt.14459. View

3.
Marconi L, Figueiredo A, Campos L, Nunes P, Roseiro A, Parada B . Renal transplantation with donors older than 70 years: does age matter?. Transplant Proc. 2013; 45(3):1251-4. DOI: 10.1016/j.transproceed.2013.02.024. View

4.
Mezrich J, Pirsch J, Fernandez L, Foley D, Bellingham J, Odorico J . Differential outcomes of expanded-criteria donor renal allografts according to recipient age. Clin J Am Soc Nephrol. 2012; 7(7):1163-71. PMC: 3386667. DOI: 10.2215/CJN.00150112. View

5.
Del Moral Martin R, Retamero Diaz J, Cava Molina M, Cobacho Tornel B, Bravo Soto J, Ortega A . Validation of KDRI/KDPI for the selection of expanded criteria kidney donors. Nefrologia (Engl Ed). 2017; 38(3):297-303. DOI: 10.1016/j.nefro.2017.08.006. View